Researchers conducted a secondary analysis of data from a comparative effectiveness trial for center-involved DME in 650 participants during 2 years of treatment with aflibercept (2mg), bevacizumab (1.25mg), or ranibizumab (0.3mg).
Your search for bevacizumab returned 70 results
Progression-free survival down with antibiotic use for patients receiving immune checkpoint inhibitors
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment, according to a study published online in Clinical Cancer Research.
Saline as good as medications for hereditary hemorrhagic telangiectasia, researchers find
Survival odds for colorectal cancer may depend on which side of the colon the primary tumor develops, according to a study released Wednesday during a media briefing that previewed some of the research to be presented at the upcoming annual meeting of the American Society of Clinical Oncology.
Herpes simplex uveitis ID’d as cause of persistently elevated intraocular pressure after cataract sx
Bevacizumab (Avastin) used to treat retinopathy of prematurity (ROP) may be linked to serious disabilities such as cerebral palsy and hearing loss, according to a study published in Pediatrics.
Both linked to improvements in visual acuity; only triamcinolone tied to sustained improvement in CMT
For patients with diabetic macular edema (DME), visual acuity (VA) improves over two years with treatment with different anti-vascular endothelial growth factor (VEGF) agents, according to a study published online in Ophthalmology.
Dose-dense weekly paclitaxel does not improve progression-free survival in ovarian cancer, according to a study published in the New England Journal of Medicine.